FDA Approves Guselkumab as First IL-23 Inhibitor with Both SC and IV Induction Options for UC and CD
- 21 September 2025
- 1 month ago
JnJ Tremfya gets USFDA approval for subcutaneous induction in adults with ulcerative colitis
- 20 September 2025
- 1 month ago
Guselkumab Efficacious Among Patients Of Psoriasis With Skin Of Color
- 31 July 2025
- 3 months ago
Recent News
SR Post VACANCIES At ESIC Model Hospital Noida, Ch...
- 02 November, 2025
Pathologist's signature on medical reports not mus...
- 02 November, 2025
UP Eyes Japanese Investment: 125 Pharma Giants Inv...
- 02 November, 2025
Delhi Govt to recruit 1,593 senior resident doctor...
- 02 November, 2025
Daily Newsletter
Get all the top stories from Blogs to keep track.



